preclinical Alzheimer's disease
Showing 1 - 25 of >10,000
PET Measures of CSF Clearance in Preclinical Alzheimer's Disease
Completed
- Mild Cognitive Impairment
-
New York, New YorkWeill Cornell Medicine
Oct 18, 2022
Alzheimer, Dementia, Preclinical Alzheimer's Disease Trial (Financial Incentives, Message)
Not yet recruiting
- Alzheimer Disease
- +3 more
- Financial Incentives
- Message
- (no location specified)
Sep 7, 2023
The Swedish BioFINDER - Preclinical AD Study
Recruiting
- Alzheimer Disease
- +2 more
- Plasma tau
- +4 more
-
Malmö, SwedenSkåne University Hospital
Nov 8, 2023
Early Stage Alzheimer's Disease Through Speech Phenotyping -
Recruiting
- Alzheimer Disease
- +5 more
-
Santa Ana, CaliforniaSyrentis Clinical Research
Apr 6, 2022
Early Stage Alzheimer's Disease From Acoustic and Linguistic
Recruiting
- Alzheimer Disease
- +4 more
-
Birmingham, United Kingdom
- +3 more
Apr 6, 2022
Preclinical Alzheimer's Disease Trial in Minneapolis (Exergame)
Completed
- Preclinical Alzheimer's Disease
- Exergame
-
Minneapolis, MinnesotaUniversity of Minnesota
Jun 6, 2022
Depression and Driving
Recruiting
- Depression
- Drive
- F 18 AV-1451 (Flortaucipir)
- [11C]-Pittsburgh Compound B ([11C]PiB)
-
Saint Louis, MissouriWashington University School of Medicine
Jul 5, 2022
Alzheimer, Preclinical Alzheimer's Disease, Prodromal Alzheimer's Disease Trial in Santa Ana
Completed
- Alzheimer Disease
- +4 more
-
Santa Ana, CaliforniaSyrentis Clinical Research
Sep 3, 2021
Alzheimer, Preclinical Alzheimer's Disease, Prodromal Alzheimer's Disease Trial in Santa Ana
Recruiting
- Alzheimer Disease
- +4 more
-
Santa Ana, CaliforniaSyrentis Clinical Research
Jun 30, 2021
Alzheimer, Preclinical Alzheimer's Disease, Prodromal Alzheimer's Disease Trial in United Kingdom
Completed
- Alzheimer Disease
- +4 more
-
Birmingham, United Kingdom
- +3 more
Sep 3, 2021
Falls: A Marker of Preclinical AD
Enrolling by invitation
- Fall
- Alzheimer Disease
-
Saint Louis, MissouriWashington University School of Medicine
Jun 25, 2021
Diabetes, Type 1, Diabetes, Type 2, Diabetes, Youth Onset Trial (PI-2620 tracer)
Not yet recruiting
- Diabetes Mellitus, Type 1
- +2 more
- PI-2620 tracer
- (no location specified)
Apr 21, 2022
Alzheimer's Disease Trial in Colombia (Crenezumab, Placebo)
Active, not recruiting
- Alzheimer's Disease
- Crenezumab
- Placebo
-
Armenia, Colombia
- +3 more
Nov 21, 2022
Population With Subjective Cognitive Decline
Recruiting
- Alzheimer Disease
- +2 more
- Observational
-
Barcelona, SpainBarcelonaBeta Brain Research Center
Nov 17, 2022
Database to Investigate Blood-Based and Digital Biomarkers in
Recruiting
- Alzheimer Disease
- +5 more
- Biomarker Data Collection
-
Aventura, Florida
- +15 more
Sep 21, 2022
Cognitive Decline by Neuroimaging Techniques and Application in
Recruiting
- Subjective Cognitive Decline
- Preclinical Alzheimer's Disease
- Neuropsychological scale
-
Beijing, Beijing, ChinaDepartment of Neurolgy,Xuanwu Hospital of Capital Medical Univer
Jun 29, 2021
Preclinical Alzheimer's Disease, Early Preclinical Alzheimer's Disease Trial in Worldwide (Lecanemab, Placebo)
Recruiting
- Preclinical Alzheimer's Disease
- Early Preclinical Alzheimer's Disease
- Lecanemab
- Placebo
-
Birmingham, Alabama
- +103 more
Jun 14, 2022
Alzheimer, Preclinical Alzheimer's Disease, Prodromal Alzheimer's Disease Trial in United Kingdom
Recruiting
- Alzheimer Disease
- +4 more
-
Birmingham, United Kingdom
- +3 more
Apr 12, 2021
Imaging Biomarkers in Preclinical and Symptomatic AD
Recruiting
- Alzheimer Disease
- [11C] Pittsburgh Compound-B (PIB)
-
Saint Louis, MissouriWashington University School of Medicine
Jun 29, 2021
Alzheimer Trial in Barcelona (Florbetaben)
Terminated
- Alzheimer Disease
- Florbetaben
-
Barcelona, SpainHospital Clínic de Barcelona
Apr 9, 2021
Clinical Human Pathologies (BRANCH-P STUDY)
Not yet recruiting
- Diabetes
- +27 more
-
Leicester, Leicestershire, United KingdomWillows Medical Centre
Aug 10, 2022
Alzheimer's Disease Trial in Madison (icosapent ethyl (IPE), gel cap )
Active, not recruiting
- Alzheimer's Disease
- icosapent ethyl (IPE)
- gel cap placebo
-
Madison, WisconsinWilliam S. Middleton Memorial Veterans Hospital, Madison, WI
Jul 23, 2021
Alzheimer's Disease Trial in Kansas City (Aerobic Exercise, Standard of Care)
Completed
- Alzheimer's Disease
- Aerobic Exercise
- Standard of Care
-
Kansas City, KansasUniversity of Kansas Medical Center
Jul 8, 2020
Alzheimer, Mild Cognitive Impairment Trial (Flortaucipir F18, Brain PET scan)
Completed
- Alzheimer Disease
- Mild Cognitive Impairment
- Flortaucipir F18
- Brain PET scan
- (no location specified)
Sep 3, 2020
Alzheimer Trial in Brescia (real-rTMS, sham-rTMS)
Recruiting
- Alzheimer Disease
- real-rTMS
- sham-rTMS
-
Brescia, ItalyIRCCS Centro San Giovanni di Dio Fatebenefratelli
Aug 2, 2023